| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |